Pulse Biosciences Inc. will participate in the Stifel 2025 Healthcare Conference in New York on November 13, 2025, where management is scheduled to present. The company leverages its nPulse technology using proprietary Nanosecond Pulsed Field Ablation energy.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pulse Biosciences Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251106527422) on November 06, 2025, and is solely responsible for the information contained therein.
Comments